FDA Policy Power Challenged In House Questions On Untitled Letters
This article was originally published in The Pink Sheet Daily
Executive Summary
Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours.
You may also be interested in...
FDA’s Untitled Letter Posting Driven By ‘Significant Public Interest,’ Not Stock Market
Response to congressional inquiry also notes that FDA's policy is not to make policy in untitled letters.
Biosimilar Naming, Interchangeability Policies Must Be Done Soon, House Tells FDA
Appropriations report sets a deadline, but doesn't include a penalty for missing it as the House had with the opioid guidance last year.
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
FDA’s draft guidance on presenting product information on social media platforms with character space limitations includes an equation for sending a tweet.